It covers list of nuclear reactors that have potential to produce Lu-177 both medium and high flux reactor with their locations all over the world. It also focuses on supply chain analysis and ...

Arguably, the step historically limiting growth of the radiotherapeutics sector is radioisotope generation. Isotopes are ...

The production of all n.c.a. Lu-177 depends on a complex and very limited global supply chain which up to now has predominantly been dependent on supply from Russia. Kinectrics is expanding our ...

Lutetium-177 is integral to this approach due to its favorable decay properties and compatibility with various targeting molecules. The success of targeted radiotherapy in clinical trials and real ...

Romania's Nuclearelectrica and France's Framatome have signed a cooperation agreement on exploring the production of the medical isotope lutetium-177 at the Cernavoda nuclear ... reliable and ...

The production of all n.c.a. Lu-177 depends on a complex and very limited global supply chain which up to now has predominantly been dependent on supply from Russia. Kinectrics is expanding our proven ...